ALLERGIES PROBLEM - WE ARE SOLVING TOGETHER!



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Recently the problem of low adherence of patients to treatment attracts more attention worldwide. WHO experts recognized the low adherence to therapy as a global international problem. In real life, the results of allergen-specific immunotherapy (ASIT) are not so beneficial first of all due to patient’s noncompliance. The cooperation between patient and physician helps to achieve positive results of the treatment. The solution of the problem of low adherence of patients requires the development of systematic approaches, and the medical community is ready to propose it.

Full Text

Restricted Access

About the authors

N G Astafieva

Saratov's State Medical University named after Razumovsky

Moscow

N I Ilina

Institute of Immunology Moscow

Moscow

O Mikhaylovna Kurbacheva

Institute of Immunology Moscow

Email: kurbacheva@gmail.com
Moscow

L S Namazova-Baranova

Federal State Budgetary Institution «Scientific Centre of Children Health» under the Russian Academy of Medical Sciences

Moscow

N M Nenasheva

Russian Academy for Postgraduate Education

Moscow

References

  1. GINA: Global Initiative for Asthma. 2014, www.ginasthma. org.
  2. Bousquet J., Khaltaev N., Cruz A.A. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008, v. 63, р. 8-160.
  3. Мурадова О.И., Намазова-Баранова Л.С., Каркашадзе Г.А. и соавт. Влияние курсов аллерген-специфической иммунотерапии на когнитивную деятельность у детей с полли-нозом. Педиатрическая фармакология. 2014, № 2, с. 6-12.
  4. Alvarez-Cuesta Е., Bousquet J. Standards for practical allergen-specific immunotherapy. Allergy. 2006, v. 61, р. 1-20.
  5. Емельянов А.В., Горячкина Л.А., Астафьева Н.Г. и соавт. Аллергический ринит и бронхиальная астма в реальной клинической практике: результаты российского многоцентрового исследования. Рос. Аллергол. Журн. 2012, № 1, с. 29-36.
  6. Федеральные клинические рекомендации по проведению аллерген-специфической иммунотерапии, РААКИ. М., 2014.
  7. Курбачёва О.М., Павлова К.С., Козулина И.Е. Аллерген специфическая иммунотерапия: история, методы и новые возможности. Медицинский совет. 2013, №3.
  8. Marogna M., Bruno M., Massolo A., Falagiani P. Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: a long-term (13-year) retrospective study in real life. Int. Arch. Allergy Immunol. 2007, v. 142, р. 70-78.
  9. Jacobsen L., Wahn U., Bilo B. M. Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorized by level of benefit - the centenary of allergen specific subcutaneous immunotherapy. Clinical and Translational Allergy. 2012, v. 2, р. 8.
  10. Ненашева Н.М. Это трудное слово «комплаенс», или Как можно повысить приверженность лечению при бронхиальной астме. Астма и аллергия. 2013, № 2, с. 15-18.
  11. Global Atlas of Asthma; Published by the European Academy of Allergy and Clinical Immunology, 2013 Available from: http:// www.eaaci.org.
  12. Global Atlas of Allergy; Published by the European Academy of Allergy and Clinical Immunology, 2014 Available from: http:// www.eaaci.org.
  13. Adherence to long-term therapy, evidence of action, World Health Organization, 2003, Available at: www.who.int. on 28.03.11.
  14. Sieber J., De Geest S., Shah-Hosseini K., Mosges R. Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates. Curr. Med. Res. Opin. Apr. 2011, v. 27, р. 855-861.
  15. Trebuchon F., David M., Demoly P. Medical management and sublingual immunotherapy practices in patients with house dust mite-induced respiratory allergy: a retrospective, observational study. Int. J. Immunopathol. Pharmacol. 2012, v. 25, р. 193-206.
  16. Kiel M.A., Roder E., Gerth van Wijk R. et al. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J. Allergy Clin. Immunol. 2013, v. 132, р. 353-360.
  17. Hsu N.M., Reisacher W.R. A comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy. Int. Forum Allergy Rhinol. 2012, v. 2, р. 280-284.
  18. Pajno G.B., Caminiti L., Crisafulli G. et al. Adherence to sublingual immunotherapy in preschool children. Pediatr. Allergy Immunol. 2012, v. 23, р. 688-689.
  19. Vita D., Caminiti L., Ruggeri P. et al. Sublingual immunotherapy: adherence based on timing and monitoring control visits. Allergy. 2010, v. 65, р. 668-669.
  20. Incorvaia C., Rapetti A., Scurati S. et al. Importance of patient’s education in favouring compliance with sublingual immunotherapy. Allergy. 2010, v. 65, р. 1341-1342.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2014



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies